Genetic risk assessment for hereditary renal cell carcinoma: Clinical consensus statement

Author:

Bratslavsky Gennady1,Mendhiratta Neil2ORCID,Daneshvar Michael13,Brugarolas James4,Ball Mark W.3ORCID,Metwalli Adam5,Nathanson Katherine L.67,Pierorazio Phillip M.8,Boris Ronald S.9,Singer Eric A.10,Carlo Maria I.11,Daly Mary B.12,Henske Elizabeth P.13,Hyatt Colette14,Middleton Lindsay4,Morris Gloria1,Jeong Anhyo2,Narayan Vivek715,Rathmell W. Kimryn16,Vaishampayan Ulka17ORCID,Lee Bruce H.18,Battle Dena19,Hall Michael J.20,Hafez Khaled21,Jewett Michael A. S.22,Karamboulas Christina22,Pal Sumanta K.23ORCID,Hakimi A. Ari11,Kutikov Alexander20,Iliopoulos Othon24,Linehan W. Marston3,Jonasch Eric25,Srinivasan Ramaprasad3,Shuch Brian2ORCID

Affiliation:

1. Department of Urology State University of New York (SUNYUpstate Medical University Syracuse New York

2. Department of Urology University of California Los Angeles Los Angeles California

3. Urologic Oncology Branch Center for Cancer Research National Cancer Institute Bethesda Maryland

4. Department of Medicine Division of Hematology‐Oncology University of Texas (UT) Southwestern Medical Center Dallas Texas

5. Department of Surgery Division of Urology Howard University Hospital Washington District of Columbia

6. Division of Human Genetics and Translational Medicine Department of Medicine Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania

7. Abramson Cancer Center Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania

8. Brady Urological Institute and Department of Urology Johns Hopkins School of Medicine Baltimore Maryland

9. Indiana University School of Medicine Indianapolis Indiana

10. Section of Urologic Oncology Rutgers Cancer Institute of New Jersey New Brunswick New Jersey

11. Memorial Sloan Kettering Cancer Center New York New York

12. Department of Clinical Genetics Fox Chase Cancer Center Philadelphia Pennsylvania

13. Department of Medicine Brigham and Women's Hospital and Harvard Medical School Boston Massachusetts

14. Sidney Kimmel Cancer Center Thomas Jefferson University Philadelphia Pennsylvania

15. Division of Hematology/Oncology Department of Medicine Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania

16. Department of Medicine Vanderbilt University Nashville Tennessee

17. Department of Oncology Karmanos Cancer Center/Wayne State University Detroit Michigan

18. Driven To Cure Silver Spring Maryland

19. The Kidney Cancer Research Alliance Leesburg Virginia

20. Department of Surgery, Division of Urology Fox Chase Cancer Center Philadelphia Pennsylvania

21. Department of Urology University of Michigan Ann Arbor Michigan

22. Division of Urology, Department of Surgery Princess Margaret Cancer Center Toronto Ontario Canada

23. Department of Medical Oncology City of Hope Comprehensive Cancer Center Duarte California

24. Massachusetts General Hospital Cancer Center Boston Massachusetts

25. The University of Texas MD Anderson Cancer Center Houston Texas

Funder

National Cancer Institute

Publisher

Wiley

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3